Article Versions Notes

Semmler G, Balcar L, Oberkofler H, Zandanell S, Strasser M, Niederseer D, Feldman A, Stickel F, Strnad P, Datz C, et al. PNPLA3 and SERPINA1 Variants Are Associated with Severity of Fatty Liver Disease at First Referral to a Tertiary Center. Journal of Personalized Medicine. 2021; 11(3):165. https://doi.org/10.3390/jpm11030165

Semmler, Georg, Lorenz Balcar, Hannes Oberkofler, Stephan Zandanell, Michael Strasser, David Niederseer, Alexandra Feldman, Felix Stickel, Pavel Strnad, Christian Datz, and et al. 2021. "PNPLA3 and SERPINA1 Variants Are Associated with Severity of Fatty Liver Disease at First Referral to a Tertiary Center" Journal of Personalized Medicine 11, no. 3: 165. https://doi.org/10.3390/jpm11030165

Semmler, G., Balcar, L., Oberkofler, H., Zandanell, S., Strasser, M., Niederseer, D., Feldman, A., Stickel, F., Strnad, P., Datz, C., Paulweber, B., & Aigner, E. (2021). PNPLA3 and SERPINA1 Variants Are Associated with Severity of Fatty Liver Disease at First Referral to a Tertiary Center. Journal of Personalized Medicine, 11(3), 165. https://doi.org/10.3390/jpm11030165